Access Patient Resources

Understanding the medical and pharmaceutical landscape is an essential – and oftentimes, first – step for any patient and their loved ones after a diagnosis. We’ve pulled together a wide range of informative resources on diseases, research, treatments, programs, coverage, and more to help patients at every step of their journey. Explore them below.

-

Report

Chart Pack: Biopharmaceuticals in Perspective, Summer 2019

This chart pack provides facts and figures about prescription medicines and their role in the health care system.

-

Video

Together - Asthma

130 medicines in development for asthma, allergies and other respiratory diseases

-

Video

Together - CAR-T

Justin's story of resilience and hope are what inspire researchers like Boris to #GOBOLDLY every day and never stop searching for a cure to end cancer.

-

Fact Sheet

Biopharmaceutical Companies’ Personalized Medicine Research Yields Innovative Treatments for Patients

The last five years have been characterized by increased momentum in personalized medicine.

-

Report

Follow the Dollar Executive Summary

Drug pricing is a complex and often confusing issue, shaped by a payment system that involves numerous stakeholders.

-

Graphic

Follow the Dollar: Flow of Payment for a $400 Insulin

Scott takes insulin for his type 2 diabetes and has a health plan with a high deductible.

-

Video

Together - ALS

Pat’s words and optimism are what inspire researchers like Pablo to #GoBoldly every day and never stop searching for a cure to end ALS.

-

Report

Medicines in Development for HIV 2017 Report

America’s biopharmaceutical research companies are developing 52 medicines and vaccines for HIV.

-

Report

List of Medicines in Development for HIV 2017

More than 50 medicines and vaccines are in development for HIV/AIDS infection treatment and prevention.

-

Fact Sheet

PREA and BPCA: Spurring Pediatric Drug Development

PREA and BPCA work together to foster pediatric drug development.

-

Video

America’s biopharmaceutical industry is central to diverse R&D ecosystem

Dr. Tim Garnett, CMO of Eli Lilly and Company, emphasizes that creating lifesaving medicines is the focus of the biopharmaceutical industry.

-

Graphic

Actual versus projected death rates for HIV/AIDS in the U.S.

The introduction of HAART treatments caused a significant drop in the HIV/AIDS death rate.

-

Video

Clinical Trials - What You Need to Know

Clinical trials are central to the work of biopharmaceutical researchers - they advance the science of bringing new medicines to the patients who need them.

-

Graphic

Falling Death Rates for HIV/AIDS Patients

This data visualization provides a look at the actual vs projected death rates for HIV/AIDs in the United States.

-

Codes & Guidelines

Principles on Interactions with Patient Organizations

Biopharmaceutical companies share many common interests with patient organizations including a common commitment to patients and a shared mission to discover cures and fight disease.